Earnings History Data for CymaBay Therapeutics Inc. (CBAY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CymaBay Therapeutics Inc.

CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-05-2023	AH	4:05 PM ET (May 15)	CBAY	CymaBay Therapeutics Inc.	1,000.00	-0.29	-0.16	-0.32	CymaBay Therapeutics GAAP EPS of -$0.29 misses by $0.19 [5/15/2023 4:07 PM]	9.57	-0.83 (-7.93%)	10.10	-0.30 (-2.88%)	1.78 - 11.22	3,525,277	1,040,000	5,236
CymaBay Therapeutics GAAP EPS of -$0.29 misses by $0.19 [5/15/2023 4:07 PM]
16-03-2023	AH	4:05 PM ET (Mar 16)	CBAY	CymaBay Therapeutics Inc.	775.44	-0.30	-0.30	-0.34	CymaBay Therapeutics GAAP EPS of -$0.30 misses by $0.01 [3/16/2023 4:08 PM]	9.61	0.46 (5.09%)	9.04	-0.10 (-1.09%)	1.67 - 10.05	3,367,908	1,920,000	2,726
CymaBay Therapeutics GAAP EPS of -$0.30 misses by $0.01 [3/16/2023 4:08 PM]
14-11-2022	AH	4:05 PM ET (Nov 14)	CBAY	CymaBay Therapeutics Inc.	296.37	-0.28	-0.30	-0.33	CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02 [11/14/2022 4:17 PM]	3.68	0.07 (1.94%)	3.51	-0.10 (-2.77%)	1.67 - 4.55	418,828	430,000	47,899
CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02 [11/14/2022 4:17 PM] CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate Update [Nov-14-22 04:06PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	CBAY	CymaBay Therapeutics Inc.	266.74	-0.31	-0.30	-0.34	CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01 [8/11/2022 4:12 PM]	4.04	0.30 (8.02%)	3.90	0.16 (4.28%)	1.67 - 4.74	438,919	770,000	2,957
CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01 [8/11/2022 4:12 PM] CymaBay Reports Second Quarter and Six Months Ended June 30, 2022 Financial Results and Provides Corporate Update [Aug-11-22 04:05PM]
12-05-2022	AH	4:05 PM ET (May 12)	CBAY	CymaBay Therapeutics Inc.	158.35	-0.32	-0.31	-0.25	CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.01 [5/12/2022 4:17 PM]	1.80	0.03 (1.40%)	2.00	0.22 (12.36%)	1.67 - 5.06	444,362	820,000	1,559
CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.01 [5/12/2022 4:17 PM] CymaBay Therapeutics Announces Presentations at Digestive Disease Week® 2022 [May-11-22 08:00AM] CymaBay Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-12-22 04:06PM] CymaBay Therapeutics Inc. (CBAY) Q1 2022 Earnings Call Transcript [May-13-22 12:00AM]
17-03-2022	AH	4:05 PM ET (Mar 17)	CBAY	CymaBay Therapeutics Inc.	251.47	-0.34	-0.36	-0.23	CymaBay Therapeutics GAAP EPS of -$0.34 misses by $0.11 [3/17/2022 4:09 PM]	3.17	-0.01 (-0.31%)	3.12	-0.06 (-1.89%)	2.67 - 5.13	1,089,791	417,308	10,177
CymaBay Therapeutics GAAP EPS of -$0.34 misses by $0.11 [3/17/2022 4:09 PM] CymaBay Reports Fourth Quarter and Year Ended December 31, 2021 Financial Results and Provides Corporate Update [Mar-17-22 04:06PM] CymaBay Announces Appointment of Éric Lefebvre, M.D. to Board of Directors [Mar-17-22 04:25PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	CBAY	CymaBay Therapeutics Inc.	302.90	-0.33	-0.29	-0.17	CymaBay Therapeutics EPS misses by $0.08 [11/10/2021 5:22 PM]	4.32	0.04 (0.93%)	4.50	0.22 (5.14%)	3.39 - 8.48	445,043	370,000	13,059
CymaBay Therapeutics EPS misses by $0.08 [11/10/2021 5:22 PM] CymaBay Reports Third Quarter and Nine Months Ended September 30, 2021 Financial Results and Provides Corporate Update [Nov-10-21 04:06PM] CymaBay Therapeutics Inc. (CBAY) Reports Q3 Loss, Misses Revenue Estimates [Nov-10-21 05:35PM] CymaBay Therapeutics to Host Post-AASLD Key Opinion Leader Webinar on Seladelpar for Primary Biliary Cholangitis [Nov-11-21 08:00AM] CymaBay Therapeutics Inc. (CBAY) Q3 2021 Earnings Call Transcript [Nov-11-21 09:00AM]
12-08-2021	AH	4:05 PM ET (Aug 12)	CBAY	CymaBay Therapeutics Inc.	263.56	-0.34	-0.27	-0.16	CymaBay Therapeutics EPS misses by $0.07 [8/12/2021 4:21 PM]	3.62	-0.34 (-8.59%)	3.85	-0.11 (-2.78%)	3.56 - 9.06	607,817	430,000	684
CymaBay Therapeutics EPS misses by $0.07 [8/12/2021 4:21 PM] CymaBay Reports Second Quarter and Six Months Ended June 30, 2021 Financial Results and Provides Corporate Update [Aug-12-21 04:06PM] CymaBay Therapeutics Inc. (CBAY) Q2 2021 Earnings Call Transcript [Aug-12-21 11:00PM]
13-05-2021	AH	4:10 PM ET (May 13)	CBAY	CymaBay Therapeutics Inc.	295.79	-0.25	-0.24	-0.19	CymaBay Therapeutics EPS misses by $0.01 [5/13/2021 4:32 PM]	4.30	0.18 (4.37%)	4.01	-0.10 (-2.55%)	3.16 - 9.06	664,611	950,000	2,180
CymaBay Therapeutics EPS misses by $0.01 [5/13/2021 4:32 PM] CymaBay Welcomes Dennis D. Kim, MD, MBA as Chief Medical Officer [May-13-21 08:00AM] CymaBay Therapeutics, Inc. to Host Earnings Call [May-13-21 02:30PM] CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-13-21 04:06PM]
25-03-2021	AH	4:05 PM ET (Mar 25)	CBAY	CymaBay Therapeutics Inc.	329.28	-0.23	-0.20	-0.35	CymaBay Therapeutics EPS misses by $0.03 [3/25/2021 4:13 PM]	4.49	-0.10 (-2.29%)	4.65	0.06 (1.31%)	1.38 - 9.06	841,157	840,000	5,491
CymaBay Therapeutics EPS misses by $0.03 [3/25/2021 4:13 PM] CymaBay Therapeutics, Inc. to Host Earnings Call [Mar-25-21 02:30PM] CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update [Mar-25-21 04:10PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	CBAY	CymaBay Therapeutics Inc.	573.83	-0.17	-0.17	-0.38	CymaBay Therapeutics EPS in-line [11/5/2020 4:27 PM]	7.83	-0.67 (-7.88%)	8.50	0.0 (0.00%)	1.21 - 9.06	1,180,174	926,128	61,412

10-08-2020	AH	4:00 PM ET (Aug 10)	CBAY	CymaBay Therapeutics Inc.	394.70	-0.16	-0.23	-0.35	CymaBay Therapeutics EPS beats by $0.08 [8/10/2020 4:23 PM]	6.03	-0.87 (-12.61%)	6.40	-0.50 (-7.25%)	1.21 - 7.09	2,666,678	9,793,502	95,048